Risk factors for persistence of pulmonary arterial branch stenosis in neonates and young infants

Y Nomura1, M Nakamura, Y Kono

  • 1Department of Pediatrics, Faculty of Medicine, Kagoshima University, Japan. uichi@m2.kufm.kagoshima-u.ac.jp

Insights

Pulmonary arterial branch stenosis (PBS) in infants often resolves by age one. However, low birth weight and high peak flow velocity differences are risk factors for persistent PBS beyond one year.

Area of Science:

  • Pediatric Cardiology
  • Neonatal Medicine
  • Cardiovascular Imaging

Background:

  • Pulmonary arterial branch stenosis (PBS) is typically considered transient in neonates.
  • However, PBS can persist into infancy, with some cases remaining after one year of age.
  • This study investigates the long-term outcomes of PBS in neonates and young infants.

Purpose of the Study:

  • To clarify the natural history of pulmonary arterial branch stenosis (PBS) in neonates and young infants.
  • To identify risk factors associated with persistent PBS beyond one year of age.
  • To evaluate the resolution rate of PBS in different patient subgroups.

Main Methods:

  • Retrospective review of 103 patients diagnosed with PBS during the neonatal period or early infancy.
  • Analysis of clinical data including birth weight, gestational age, and Doppler echocardiography parameters.
  • Comparison of patient characteristics and outcomes between those with resolved PBS and persistent PBS.

Main Results:

  • All studied cases of PBS showed improvement.
  • Pulmonary arterial branch stenosis resolved by age one in 94 patients.
  • Nine patients (group B) had persistent PBS after age one, with significantly lower birth weight and higher deltavelocity (>1.2 m/s) at diagnosis compared to resolved cases (group A).
  • Low birth weight (<2,500 g) and high deltavelocity were identified as significant risk factors for persistent PBS.

Conclusions:

  • Pulmonary arterial branch stenosis in neonates and infants generally resolves.
  • Low birth weight and a deltavelocity above 1.2 m/s are identified as key risk factors for persistent PBS.
  • Patients without these risk factors demonstrated a high rate of PBS resolution by age one.
Abstract

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...